Position in TNGX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,046,788
+$2,956,971 QoQ
Shares Held
145,640
+122.1% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALGERT GLOBAL LLC holds $437,724,004 across 106 Biotechnology names. TNGX ranks #47 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
827,454 | $22,920,475 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
135,460 | $22,895,449 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
928,568 | $21,691,348 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
363,984 | $21,151,110 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
283,921 | $21,083,973 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
264,200 | $15,363,230 | |
| 7 | MRNA |
Moderna, Inc.
|
237,418 | $12,060,834 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
563,999 | $11,031,820 |
All Filings in TNGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,046,788 | 145,640 | Shares | Sole | 2026-05-14 | |
| 2025-03-31 | $89,817 | 65,560 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $501,507 | 162,300 | Shares | Sole | 2025-02-14 | |
| 2023-06-30 | $133,092 | 40,088 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $158,347 | 40,088 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $307,929 | 42,473 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $124,611 | 34,423 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $76,874 | 16,970 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||